The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODOShionogi, hospital to research development of nasal COVID-19 vaccine
TOKYO©2024 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODO
7 Comments
Login to comment
kurisupisu
I’m betting that the next ‘variant’ won’t be a concern.
Shinogi’s Covid-19 spray just might be too late.
WilliB
Sounds completely reasonable for an airborne virus. Many virologists (like the much maligned Prof. Bagdi from Germany) said already at the beginning of the pandemic that injecting vaccines into the muscle (or worse, bloodstream) for a virus with this entry vector is problematic approach. Unsurprisingly, major institutions and corporate media defamed and ignored him and other critics.
TokyoLiving
Great news too..
This news because science rules..
Tatemae or not, Japan is doing something against covid..
Less feelings and more facts..
Ingvar
The Russians have already done it.
Tom Doley
Why is this news? If they fail to develop, will that also be news? More tatemae to show the world that Japan is innovating.
snowymountainhell
Really covering the Shionogi news extensively in the last 3 months.